Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm Files $100M Shelf Registration

NEW YORK (GenomeWeb News) – Fluidigm today filed a shelf registration to offer from time to time up to $100 million in securities.

In its Form S-3 filed with the US Securities and Exchange Commission, the South San Francisco, Calif.-based firm said that proceeds would go toward working capital and other general corporate purposes. A portion may also be used to acquire and invest in complementary products, technologies, or businesses, though Fluidigm added that it currently is not involved in any commitments or negotiations for such transactions.

Fluidigm President and CEO Gajus Worthington said at an investment conference in January that the firm is "quite interested" in acquisitions that would complement its portfolio.

In the SEC filing today, it said that securities that may be offered include any combinations of common stock, preferred stock, debt securities, and warrants.

Fluidigm went public in February 2011, netting $78 million in proceeds. The company recently reported a 26 percent hike year over year in revenues for the fourth quarter.

Filed under

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.